Shire Plans to Complete Two More ProAmatine Trials by 2014

Washington Drug Letter
A A
Shire expects to complete two additional efficacy trials of blood-pressure drug ProAmatine by 2014 after reaching an agreement with CDER for postmarket trials of the accelerated approval drug.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00